Answers are grounded in this paper and cite their sources.
Introduction The Morisky Medication Adherence Scale (MMAS-8) is widely used to assess medication adherence, yet its psychometric properties have not been evaluated in Ecuador. Objective This study examined the reliability, factorial structure, and convergent validity of the MMAS-8 in Ecuadorian patients diagnosed with neuropsychiatric disorders. Results A total of 440 patients with neuropsychiatric disorders completed the MMAS-8. Internal consistency was evaluated with Cronbach’s alpha and McDonald’s omega. Confirmatory factor analysis (CFA) supported the original one-factor model with adequate fit (RMSEA = 0.08, SRMR = 0.06, CFI = 0.92, TLI = 0.90, α = 0.70, ω = 0.71). A two-factor model was also examined. Confirmatory factor analysis (CFA) supported the two-factor model with adequate fit (RMSEA = 0.08, SRMR = 0.07, CFI = 0.92, TLI = 0.90, α = 0.70, ω = 0.72). The scale showed acceptable internal consistency (ω = 0.71), and all items correlated positively (r > 0.20; p < 0.001). A two-factor solution produced only a slight improvement in model fit. Conclusion The MMAS-8 appears to be a reliable and valid instrument for assessing medication adherence in Ecuadorian patients with neuropsychiatric disorders, supporting its use in clinical practice and research.
No takes yet. Share an insight, caveat, or question.
Figueira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: